Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell J Butterfield

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Neurology|January 21, 2021
Population-Based Prevalence of Myotonic Dystrophy Type 1 Using Genetic Analysis of Statewide Blood Screening ProgramNicholas E Johnson, Russell J Butterfield, Katie Mayne, et al.
Muscle & Nerve|January 7, 2022
Evaluation of effects of continued corticosteroid treatment on cardiac and pulmonary function in non-ambulatory males with Duchenne muscular dystrophy from MD STARnetRussell J Butterfield, Sergey Kirkov, Kristin M Conway, et al.
Children (Basel, Switzerland)|October 23, 2021
Characteristics of Clinical Trial Participants with Duchenne Muscular Dystrophy: Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STAR<i>net</i>)Katherine D Mathews, Kristin M Conway, Amber M Gedlinske, et al.
Molecular Genetics & Genomic Medicine|February 24, 2021
High throughput screening for expanded CTG repeats in myotonic dystrophy type 1 using melt curve analysisRussell J Butterfield, Carina Imburgia, Katie Mayne, et al.
The Lancet. Respiratory Medicine|April 1, 2022
Cardiorespiratory management of Duchenne muscular dystrophy: emerging therapies, neuromuscular genetics, and new clinical challengesDavid J Birnkrant, Luca Bello, Russell J Butterfield, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2002
Interacting quantitative trait loci control loss of peripheral tolerance and susceptibility to autoimmune ovarian dysgenesis after day 3 thymectomy in miceRandall J Roper, Runlin Z Ma, Julia E Biggins, et al.
Neurology|February 15, 2024
Neurobehavioral Phenotype of Children With Congenital Myotonic DystrophyNamita Patel, Kiera N Berggren, Man Hung, et al.
Muscle & Nerve|June 15, 2018
Orofacial strength, dysarthria, and dysphagia in congenital myotonic dystrophyKiera N Berggren, Man Hung, Melissa M Dixon, et al.
Scientific Reports|November 6, 2022
Dual-energy X-ray absorptiometry measures of lean body mass as a biomarker for progression in boys with Duchenne muscular dystrophySarah P Sherlock, Jeffrey Palmer, Kathryn R Wagner, et al.
Neurology|May 14, 2025
Delandistrogene Moxeparvovec Gene Therapy in Individuals With Duchenne Muscular Dystrophy: Evidence in Focus: Report of the AAN Guidelines SubcommitteeMaryam Oskoui, Tracie Anne Caller, Julie A Parsons, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Neurology|January 21, 2021
Population-Based Prevalence of Myotonic Dystrophy Type 1 Using Genetic Analysis of Statewide Blood Screening ProgramNicholas E Johnson, Russell J Butterfield, Katie Mayne, et al.
Muscle & Nerve|January 7, 2022
Evaluation of effects of continued corticosteroid treatment on cardiac and pulmonary function in non-ambulatory males with Duchenne muscular dystrophy from MD STARnetRussell J Butterfield, Sergey Kirkov, Kristin M Conway, et al.
Children (Basel, Switzerland)|October 23, 2021
Characteristics of Clinical Trial Participants with Duchenne Muscular Dystrophy: Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STAR<i>net</i>)Katherine D Mathews, Kristin M Conway, Amber M Gedlinske, et al.
Molecular Genetics & Genomic Medicine|February 24, 2021
High throughput screening for expanded CTG repeats in myotonic dystrophy type 1 using melt curve analysisRussell J Butterfield, Carina Imburgia, Katie Mayne, et al.
The Lancet. Respiratory Medicine|April 1, 2022
Cardiorespiratory management of Duchenne muscular dystrophy: emerging therapies, neuromuscular genetics, and new clinical challengesDavid J Birnkrant, Luca Bello, Russell J Butterfield, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2002
Interacting quantitative trait loci control loss of peripheral tolerance and susceptibility to autoimmune ovarian dysgenesis after day 3 thymectomy in miceRandall J Roper, Runlin Z Ma, Julia E Biggins, et al.
Neurology|February 15, 2024
Neurobehavioral Phenotype of Children With Congenital Myotonic DystrophyNamita Patel, Kiera N Berggren, Man Hung, et al.
Muscle & Nerve|June 15, 2018
Orofacial strength, dysarthria, and dysphagia in congenital myotonic dystrophyKiera N Berggren, Man Hung, Melissa M Dixon, et al.
Scientific Reports|November 6, 2022
Dual-energy X-ray absorptiometry measures of lean body mass as a biomarker for progression in boys with Duchenne muscular dystrophySarah P Sherlock, Jeffrey Palmer, Kathryn R Wagner, et al.
Neurology|May 14, 2025
Delandistrogene Moxeparvovec Gene Therapy in Individuals With Duchenne Muscular Dystrophy: Evidence in Focus: Report of the AAN Guidelines SubcommitteeMaryam Oskoui, Tracie Anne Caller, Julie A Parsons, et al.
Pageof 8